Imdex Limited
Imdex Limited Fundamental Analysis
Imdex Limited (IMD.AX) shows weak financial fundamentals with a PE ratio of 37.66, profit margin of 10.82%, and ROE of 7.87%. The company generates $0.5B in annual revenue with weak year-over-year growth of -3.12%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 40.6/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze IMD.AX's fundamental strength across five key dimensions:
Efficiency Score
WeakIMD.AX struggles to generate sufficient returns from assets.
Valuation Score
ModerateIMD.AX shows balanced valuation metrics.
Growth Score
ModerateIMD.AX shows steady but slowing expansion.
Financial Health Score
ExcellentIMD.AX maintains a strong and stable balance sheet.
Profitability Score
WeakIMD.AX struggles to sustain strong margins.
Key Financial Metrics
Is IMD.AX Expensive or Cheap?
P/E Ratio
IMD.AX trades at 37.66 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, IMD.AX's PEG of -25.11 indicates potential undervaluation.
Price to Book
The market values Imdex Limited at 2.91 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 13.32 times EBITDA. This signals the market has high growth expectations.
How Well Does IMD.AX Make Money?
Net Profit Margin
For every $100 in sales, Imdex Limited keeps $10.82 as profit after all expenses.
Operating Margin
Core operations generate 16.05 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $7.87 in profit for every $100 of shareholder equity.
ROA
Imdex Limited generates $5.70 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Imdex Limited generates strong operating cash flow of $118.40M, reflecting robust business health.
Free Cash Flow
Imdex Limited generates strong free cash flow of $62.89M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.12 in free cash annually.
FCF Yield
IMD.AX converts 3.31% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
37.66
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-25.11
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.91
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.08
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.24
vs 25 benchmark
Current Ratio
Current assets to current liabilities
2.55
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.08
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
0.09
vs 25 benchmark
How IMD.AX Stacks Against Its Sector Peers
| Metric | IMD.AX Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 37.66 | 25.96 | Worse (Expensive) |
| ROE | 7.87% | 1263.00% | Weak |
| Net Margin | 10.82% | -41827.00% (disorted) | Strong |
| Debt/Equity | 0.24 | 0.79 | Strong (Low Leverage) |
| Current Ratio | 2.55 | 10.05 | Strong Liquidity |
| ROA | 5.70% | -1497918.00% (disorted) | Weak |
IMD.AX outperforms its industry in 3 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Imdex Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
39.00%
Industry Style: Cyclical, Value, Infrastructure
High GrowthEPS CAGR
94.27%
Industry Style: Cyclical, Value, Infrastructure
High GrowthFCF CAGR
79.96%
Industry Style: Cyclical, Value, Infrastructure
High Growth